Norma terapêutica da diabetes mellitus tipo 2: metformina uma perspectiva crítica

Translated title of the contribution: Guideline: type 2 diabetes mellitus therapy: metformin a critical perspective

Daniel José Leiras Leal Pinto, Bruno Miguel Costa Heleno, Rosa Gallego, Isabel Santos, Luiz Miguel Santiago, Vasco Maria

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
74 Downloads (Pure)

Abstract

Clinical guidelines have the potential to increase health gains, but also to cause harm. In this opinion article we state some misgivings about the application of the Portuguese National Health Directorate's guideline type 2 diabetes therapy: metformin in primary care. We seek to highlight guideline wording that may allow for multiple interpretations (alternatives to monotherapy with metformin, hierarchy of drugs to be associated with metformin, and metformin contraindications). Furthermore, we argue that it seems that choosing a glycemic target of 6.5% in a normative document to be applied in the general population may have unforeseen consequences.
Translated title of the contributionGuideline: type 2 diabetes mellitus therapy: metformin a critical perspective
Original languagePortuguese
Pages (from-to)331-338
Number of pages8
JournalActa Médica Portuguesa
Volume24
Issue number2
Publication statusPublished - Mar 2011

Keywords

  • CLINICAL-PRACTICE GUIDELINES
  • BLOOD-GLUCOSE CONTROL
  • GENERAL-PRACTITIONERS
  • EUROPEAN-ASSOCIATION
  • POTENTIAL BENEFITS
  • HEART-FAILURE
  • HEALTH-CARE
  • CONTRAINDICATIONS
  • OUTCOMES
  • COMPLICATIONS

Fingerprint

Dive into the research topics of 'Guideline: type 2 diabetes mellitus therapy: metformin a critical perspective'. Together they form a unique fingerprint.

Cite this